当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析 - 现金流量表

梅花生物

(600873)

  

流通市值:298.97亿  总市值:298.97亿
流通股本:28.53亿   总股本:28.53亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金6,460,790,151.4727,266,900,172.1120,292,035,951.8613,389,911,638.6
收到的税费返还135,732,651.36590,412,944.2459,602,997.84330,068,330.01
收到其他与经营活动有关的现金158,096,619.85448,943,253.14355,718,519.67302,955,156.78
经营活动现金流入的平衡项目0000
经营活动现金流入小计6,754,619,422.6828,306,256,369.4521,107,357,469.3714,022,935,125.39
购买商品、接受劳务支付的现金5,141,844,989.2320,140,823,405.614,374,153,645.819,916,642,628.2
支付给职工以及为职工支付的现金483,716,5621,968,598,894.61,531,863,315.081,120,919,599.52
支付的各项税费273,103,809.51859,863,649.52606,174,050.88425,300,472.8
支付其他与经营活动有关的现金402,686,991.25710,255,629.26509,454,533.85324,254,301.75
经营活动现金流出的平衡项目0000
经营活动现金流出小计6,301,352,351.9923,679,541,578.9817,021,645,545.6211,787,117,002.27
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额453,267,070.694,626,714,790.474,085,711,923.752,235,818,123.12
二、投资活动产生的现金流量:
收回投资收到的现金23,752,887.87190,804,566.6812,840,00037,400,000
取得投资收益收到的现金7,969,507.5951,309,310.7124,609,93010,871,635.28
处置固定资产、无形资产和其他长期资产收回的现金净额3,707.83,487,009.21,237,1961,065,812
投资活动现金流入的平衡项目0000
投资活动现金流入小计31,726,103.26245,600,886.5938,687,12649,337,447.28
购建固定资产、无形资产和其他长期资产支付的现金552,920,288.672,004,423,105.691,425,811,689.21,048,684,780.6
投资支付的现金1,629,455,144881,089,058.612,342,886,143.381,094,050,606.66
支付其他与投资活动有关的现金472,5009,047,530--
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,182,847,932.672,894,559,694.33,768,697,832.582,142,735,387.26
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-2,151,121,829.41-2,648,958,807.71-3,730,010,706.58-2,093,397,939.98
三、筹资活动产生的现金流量:
取得借款收到的现金1,459,109,699.946,297,183,657.374,914,588,328.043,556,386,998.94
收到其他与筹资活动有关的现金165,062,467.78389,646,523.23287,772,154.46235,856,949.53
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,624,172,167.726,686,830,180.65,202,360,482.53,792,243,948.47
偿还债务支付的现金1,253,360,0006,411,943,930.695,106,015,680.693,573,136,295.58
分配股利、利润或偿付利息支付的现金12,265,180.311,789,239,618.911,268,690,731.641,171,823,531.2
支付其他与筹资活动有关的现金182,309,929.841,223,698,914.69670,263,213.09503,808,378.73
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,447,935,110.159,424,882,464.297,044,969,625.425,248,768,205.51
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额176,237,057.57-2,738,052,283.69-1,842,609,142.92-1,456,524,257.04
四、汇率变动对现金及现金等价物的影响22,189,675.61111,541,460.3471,035,361.9668,078,736.56
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,499,428,025.54-648,754,840.59-1,415,872,563.79-1,246,025,337.34
加:期初现金及现金等价物余额4,131,859,602.264,780,614,442.734,780,614,442.734,780,614,442.73
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,632,431,576.724,131,859,602.143,364,741,878.943,534,589,105.39
补充资料:
净利润-2,740,427,215.56-1,473,823,789.92
资产减值准备-6,981,927.26-1,987,907.91
固定资产和投资性房地产折旧-1,275,227,848.29-644,467,539.02
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,275,227,848.29-644,467,539.02
无形资产摊销-45,749,650.73-21,594,903.82
长期待摊费用摊销-36,976,072.81-14,792,568.72
处置固定资产、无形资产和其他长期资产的损失--29,968.32--1,598,224.17
固定资产报废损失-34,405,586.69-24,205,123.35
公允价值变动损失--14,826,169.53--1,959,926.94
财务费用--29,377,272.58--23,730,451.06
投资损失--30,193,009.09--14,671,408.04
递延所得税-15,127,342.15-23,261,630.32
其中:递延所得税资产减少-14,034,060.21-24,645,983.8
递延所得税负债增加-1,093,281.94--1,384,353.48
存货的减少-202,965,494.39-416,520,802.04
经营性应收项目的减少-306,096,165.23-253,649,805.16
经营性应付项目的增加-37,357,071.5--591,564,282.59
现金的期末余额-4,131,859,602.14-3,534,589,105.39
减:现金的期初余额-4,780,614,442.73-4,780,614,442.73
公告日期2025-04-222025-03-182024-10-232024-07-30
审计意见(境内)标准无保留意见
TOP↑